MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effect of deep brain stimulation on clinical outcome in Parkinson’s disease patients with different genetic status

M. Kestenbaum, R. Schvartz, Y. Balash, A. Hilel, A. Mirelman, N. Giladi, T. Gurevich (Tel Aviv, Israel)

Meeting: 2018 International Congress

Abstract Number: 1287

Keywords: Deep brain stimulation (DBS), Leucine-rich repeat kinase 2(LRRK2), Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The aim of this study was to evaluate the effect of the genetic status on the clinical outcome of PD patients undergoing DBS.

Background: Mutations in the LRRK2 and GBA gene are highly prevalent in Ashkenazi Jewish Parkinson’s disease (PD) patients. Deep brain stimulation (DBS) surgery is an effective treatment for a subgroup of PD patients. Genetic status of patients has not been assessed as part of the presurgical evaluation.

Methods: This retrospective study was conducted in the MDU at the Tel Aviv Sourasky Medical Center. PD patients who underwent DBS in the years 2005-2015 and had genetic testing for LRRK2 G2019S and GBA genes mutations were asked for permission to participate in the study. Assessment included evaluation of the medical records and clinical global impression of change questionnaire (CGIC) was completed via a telephone call with the patient and the caregiver.

Results: 55 Ashkenazi Jewish PD patients after subthalamic DBS (9 with LRRK2 G2019S mutation, 5 with one of the 7 frequent GBA mutations, 41 had no mutation) were evaluated. The three groups did not differ in the presurgical motor symptoms and in the Unified Parkinson’s Disease Rating Scale part 3OFF scores. No between groups differences were seen in the CGIC one, three and five years following DBS. One year following DBS, the majority of patients reported improvement in general condition (86%), OFF periods (94%), tremor (67%), gait (61%) and dyskinesia (47%). Improvement in general condition was lower three and five years following DBS (34% and 17% respectively). Deterioration in in general condition was reported in 8% patients one year following DBS and increased gradually to 35% after five years.

Conclusions: In this cohort the genetic status did not affect the clinical outcome of PD patients undergoing DBS surgery. Due to limitations of this study, further evaluation of a large cohort of patients in an extended prospective multicenter study is needed. *This poster has been presented in the Israeli Neurological association conference in 12.2017

To cite this abstract in AMA style:

M. Kestenbaum, R. Schvartz, Y. Balash, A. Hilel, A. Mirelman, N. Giladi, T. Gurevich. Effect of deep brain stimulation on clinical outcome in Parkinson’s disease patients with different genetic status [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/effect-of-deep-brain-stimulation-on-clinical-outcome-in-parkinsons-disease-patients-with-different-genetic-status/. Accessed July 6, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effect-of-deep-brain-stimulation-on-clinical-outcome-in-parkinsons-disease-patients-with-different-genetic-status/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley